Catalyst Wire Dossier Catalyst Wire Dossier

Gazyva

Obinutuzumab · Genentech
Drug timelines are a Plus or Pro feature.

65 regulatory and trial events tracked for Gazyva, covering 2013-11-01 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL) [Phase 3]

See pricing